37.35
+0.03%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Omnicell
From its filings with the US Securities and Exchange Commission
Omnicell is based in Fort Worth, Texas and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker OMCL. The SEC classifies its business as electronic computers. In the fiscal year to 31 December 2025, it reported revenue of $1.18bn and net income of $2.1m. At that date it held total assets of $1.97bn and shareholders' equity of $1.23bn. By region, United States accounted for 89.9%, followed by Rest of world at 10.1%.
Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. We are doing this with an industry-leading medication management infrastructure which includes storage and dispensing automation powered by an intelligence ecosystem. Our comprehensive set of solutions provides the critical foundation for customers to realize the Autonomous Pharmacy, an industry-wide vision defined by pharmacy leaders for improving operational efficiencies and ultimately targeting zero-error medication management alongside 5 other outcomes laid out in the Autonomous Pharmacy framework.
Quoted from its 10-K, filed 26 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 8 Aug 2001
- Employees
- 3,580
- Website
- omnicell.com ↗
- Head office
- 4220 NORTH FREEWAY, FORT WORTH, TX, 76137
- Incorporated in
- DE
- Classification
- Electronic Computers
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Randall LippsChairman of the Board, President, Chief Executive Officer, since 1992$8.2m
- Mr. Nchacha EttaChief Financial Officer, Executive Vice President$3.1m
- Mr. Baird RadfordChief Financial Officer, Executive Vice President
- Mr. Nnamdi NjokuChief Operating Officer, Executive Vice President$2.7m
- Mr. Corey ManleyExecutive Vice President, Chief Legal and Administrative Officer$2.7m
- Ms. Joanne BauerLead Independent Director$342,605
- Mr. Edward BousaIndependent Director$286,392
- Ms. Mary GarrettIndependent Director$295,811
- Mr. Kaushik GhoshalIndependent Director$279,929
- Mr. Mark ParrishIndependent Director$311,023
- Mr. Bruce ScottIndependent Director$310,138
- Mr. Robin SeimIndependent Director, since 2006$297,273
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 73
- Environment
- 99
- Social
- 84
- Governance
- 36
- Direct emissions (scope 1)
- 335 t
- Energy emissions (scope 2)
- 4,910 t
- Women in the workforce
- 40%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Omnicell Inc possesses several strengths that contribute to its success in the market:
Weaknesses
- Despite its strengths, Omnicell Inc also faces certain weaknesses that can hinder its growth:
Opportunities
- Omnicell Inc can leverage the following opportunities to further expand its business:
Threats
- Omnicell Inc faces the following threats that could negatively impact its performance:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.